Dyne-102

N/A

Report date: 2022/04/06 13:51:29

Base Information

Drug NameDyne-102
Drug Alias NameDyne-102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragment
Mechanisms of ActionMyotonin-protein kinase inhibitorsGene silencing
TargetsMyotonin-protein kinase
Therapy Area/IndicationsMyotonic Dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDyne Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDyne Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyotonic Dystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A